Similar articles

• [Oral contraception increases the chance of venous thrombosis in factor V Leiden mutation].

  Vandenbroucke JP, Briët E, Helmerhorst F, van der Meer FJ. Vandenbroucke JP, et al. Ned Tijdschr Geneeskd. 1995 May 27;139(21):1067-71. Ned Tijdschr Geneeskd. 1995. PMID: 7783798 Review. Dutch. No abstract available.
• Prophylaxis and treatment of thrombophlebitis.

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 1970 Jan 23;12(2):6-8. Med Lett Drugs Ther. 1970. PMID: 5510012 No abstract available.
• Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.

  Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F. Aznar J, et al. Haematologica. 2000 Dec;85(12):1271-6. Haematologica. 2000. PMID: 11114134
• Factor V Leiden mutation and venous thrombosis.

  Hatake K, Miura Y. Hatake K, et al. Lancet. 1995 Jan 14;345(8942):133. Lancet. 1995. PMID: 7815876 No abstract available.
• [Significance of hereditary thrombophilia for risk of thrombosis with oral contraceptives].

  Bauersachs R, Lindhoff-Last E, Ehrly AM, Kuhl H. Bauersachs R, et al. Zentralbl Gynakol. 1996;118(5):262-70. Zentralbl Gynakol. 1996. PMID: 8701622 Review. German.